MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1146.64%
Quick Ratio
1146.64%
Cash Ratio
1100.48%
Debt to Asset Ratio
3.72%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets
    • Cash and cash equivalents
    • Goodwill
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
13,756
16,977
18,672
16,862
Receivables
20
20
20
20
Prepaid expenses
557
383
519
416
Total current assets
14,333
17,380
19,211
17,298
Equipment, net
7
8
11
12
Intangible assets
27,595
41,128
41,128
41,128
Goodwill
8,138
8,138
8,138
8,138
Total assets
50,073
66,654
68,488
66,576
Trade and other payables
1,250
2,146
1,284
1,245
Total current liabilities
1,250
2,146
1,284
1,245
Derivative warrant liabilities
-
0
0
201
Deferred tax liability
612
612
2,312
2,312
Total liabilities
1,862
2,758
3,596
3,758
Common stock, 0.0001 par value per share 100,000,000 authorized 16,274,026 and 16,024,026 shares issued and outstanding as of june 30, 2026 and march 31, 2026, respectively
1
1
1
1
Additional paid-in capital
298,518
298,413
298,231
293,842
Accumulated other comprehensive loss
-6,038
-6,038
-6,038
-6,038
Accumulated deficit
-244,270
-228,480
-227,302
-224,987
Total stockholders' equity
48,211
63,896
64,892
62,818
Total liabilities and stockholders equity
50,073
66,654
68,488
66,576
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$13,756K (-31.24%↓ Y/Y)Prepaid expenses$557K (11.40%↑ Y/Y)Receivables$20K (0.00%↑ Y/Y)Intangible assets$27,595K (-32.90%↓ Y/Y)Total current assets$14,333K (-30.17%↓ Y/Y)Goodwill$8,138K (0.00%↑ Y/Y)Equipment, net$7K (-50.00%↓ Y/Y)Total assets$50,073K (-28.27%↓ Y/Y)Total liabilities andstockholders equity$50,073K (-28.27%↓ Y/Y)Total stockholders'equity$48,211K (-24.14%↓ Y/Y)Total liabilities$1,862K (-70.23%↓ Y/Y)Accumulated deficit-$244,270K (-9.03%↓ Y/Y)Accumulated othercomprehensive loss-$6,038K (0.00%↑ Y/Y)Additional paid-in capital$298,518K (1.66%↑ Y/Y)Total currentliabilities$1,250K (-46.00%↓ Y/Y)Deferred tax liability$612K (-73.53%↓ Y/Y)Common stock, 0.0001par value per share...$1K (0.00%↑ Y/Y)Trade and otherpayables$1,250K (-46.00%↓ Y/Y)

Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics, Inc. (GRCE)